BK virus antibody titers and intensity of infections after renal transplantation

被引:92
作者
Bohl, Daniel L. [2 ]
Brennan, Daniel C. [2 ]
Ryschkewitsch, Caroline [3 ]
Gaudreault-Keener, Monique [4 ]
Major, Eugene O. [3 ]
Storch, Gregory A. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[3] NINDS, Lab Mol Med & Neurosci, Bethesda, MD 20892 USA
[4] St Louis Childrens Hosp, Virol Lab, St Louis, MO 63110 USA
关键词
Polyomavirus; BK virus; BK-antibody; BK-viremia; Humoral immunity; Transplantation; Kidney;
D O I
10.1016/j.jcv.2008.06.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The mean urine BK viral load in kidney transplant recipients increases with the intensity of infection as the infection progresses from transient viruria to sustained viremia. Objectives: This study investigated whether the intensity of infection is associated with the humoral immune response. Study design: We measured BKV-specific IgG antibody titers in stored samples obtained serially over a 1-year period from 70 kidney transplant recipients with BKV infection and 17 control recipients without active BKV infection. Results: The mean pre-transplant BKV antibody level was lower in recipients who developed viremia than the mean level in those who never developed viremia (p = 0.004). Mean antibody titers in recipients who never showed evidence of active BKV infection rose slightly after transplant despite immunosuppression. The magnitude of the rise in the mean antibody titers in recipients who developed active BKV infection correlated with the intensity of infection (p < 0.001). Conclusions: The mean antibody level increased in accordance with the intensity of the infection post-transplant. Pre-transplant seropositivity did not protect against sustained viremia and the antibody response was not associated with clearance of the virus. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 22 条
[1]   BK PAPOVAVIRUS INFECTIONS IN RENAL-TRANSPLANT RECIPIENTS - CONTRIBUTION OF DONOR KIDNEYS [J].
ANDREWS, C ;
SHAH, KV ;
RUBIN, R ;
HIRSCH, M .
JOURNAL OF INFECTIOUS DISEASES, 1982, 145 (02) :276-276
[2]   Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients [J].
Binggeli, S. ;
Egli, A. ;
Schaub, S. ;
Binet, I. ;
Mayr, M. ;
Steiger, J. ;
Hirsch, H. H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1131-1139
[3]   Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia [J].
Bohl, DL ;
Storch, GA ;
Ryschkewitsch, C ;
Gaudreault-Keener, M ;
Schnitzler, MA ;
Major, EO ;
Brennan, DC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) :2213-2221
[4]   Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction [J].
Brennan, DC ;
Agha, I ;
Bohl, DL ;
Schnitzler, MA ;
Hardinger, HL ;
Lockwood, M ;
Torrence, S ;
Schuessler, R ;
Roby, T ;
Gaudreault-Keener, M ;
Storch, GA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) :582-594
[5]   Polyomavirus BK-specific immunity after kidney transplantation [J].
Comoli, P ;
Azzi, A ;
Maccario, R ;
Basso, S ;
Botti, G ;
Basile, G ;
Fontana, L ;
Labirio, M ;
Cometa, A ;
Poli, F ;
Perfumo, F ;
Locatelli, F ;
Ginevri, F .
TRANSPLANTATION, 2004, 78 (08) :1229-1232
[6]   PROSPECTIVE-STUDY OF THE HUMAN POLYOMAVIRUSES BK AND JC AND CYTOMEGALOVIRUS IN RENAL-TRANSPLANT RECIPIENTS [J].
GARDNER, SD ;
MACKENZIE, EFD ;
SMITH, C ;
PORTER, AA .
JOURNAL OF CLINICAL PATHOLOGY, 1984, 37 (05) :578-586
[7]  
GARDNER SD, 1971, LANCET, V1, P1253
[8]   Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients [J].
Ginevri, F. ;
Azzi, A. ;
Hirsch, H. H. ;
Basso, S. ;
Fontana, I. ;
Cioni, M. ;
Bodaghi, S. ;
Salotti, V. ;
Rinieri, A. ;
Botti, G. ;
Perfumo, F. ;
Locatelli, F. ;
Comoli, P. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) :2727-2735
[9]   Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches [J].
Ginevri, F ;
de Santis, R ;
Comoli, P ;
Pastorino, N ;
Rossi, C ;
Botti, G ;
Fontana, I ;
Nocera, A ;
Cardillo, M ;
Ciardi, MR ;
Locatelli, F ;
Maccario, R ;
Perfumo, F ;
Azzi, A .
TRANSPLANTATION, 2003, 75 (08) :1266-1270
[10]  
Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105